Background: Molecular and behavioral studies support a role for innate immune proinflammatory pathways in mediating the effects of alcohol. Increased levels of Toll-like receptors (TLRs) have been observed in animal models of alcohol consumption and in human alcoholics, and many of these TLRs signal via the MyD88-dependent pathway. We hypothesized that this pathway is involved in alcohol drinking and examined some of its key signaling components.
N EUROIMMUNE AND PROINFLAMMATORY signaling mediate some of the acute and chronic effects of alcohol and support a neuroimmune hypothesis of alcohol addiction (Crews and Vetreno, 2016; Mayfield et al., 2013; Robinson et al., 2014) . The immune activator, lipopolysaccharide (LPS), induced prolonged increases in ethanol (EtOH) consumption in mice (Blednov et al., 2011) , and chronic intermittent EtOH intake or LPS treatment produced overlapping changes in mouse brain transcriptomes (Osterndorff-Kahanek et al., 2013) . In addition, deletion of neuroimmune-related genes that were associated with EtOH drinking based on meta-analyses in mice (Mulligan et al., 2006) , rats (Kimpel et al., 2007) , and humans (FlatscherBader et al., 2008; Liu et al., 2006 Liu et al., , 2007 decreased EtOH intake in mice and provided behavioral validation of the genomic evidence (Blednov et al., 2012b) . Research is currently focused on the neuroimmune pathways that are directly involved in regulating alcohol drinking and identifying drugs to target the predominant pathways.
Toll-like receptors (TLRs) are a major component of innate immune signaling and have been hypothesized to mediate some effects of chronic alcohol in the brain in animal models and human alcoholics (Crews and Vetreno, 2016; Montesinos et al., 2016a) . Increased levels of TLR mRNA and/or protein were reported in mouse brain following chronic and binge-like EtOH exposure as well as in human postmortem brain from alcoholics (Robinson et al., 2014) . A few studies have suggested a role for TLR4 in EtOH drinking June et al., 2015; Liu et al., 2011) , although this has not been consistently observed (Alfonso-Loeches et al., 2010; Bajo et al., 2016; Harris et al., 2016; Pascual et al., 2011) . The TLR family in mammals consists of 13 known members that are essential for defense against pathogens and are known as pathogen-associated molecular patterns (Beutler, 2009 ). Many TLRs (e.g., TLR2 and TLR4) utilize the co-receptor CD14 for signal recognition (Chun and Seong, 2010) . Ligand recognition by TLRs leads to the recruitment of downstream adapters such as MyD88 (Myeloid differentiation primary response protein MyD88), TIRAP (Toll/interleukin-1 receptor [TIR] domaincontaining adapter protein), TRIF (TIR domain-containing adapter protein inducing interferon-b), and TRAM (TIR domain-containing adapter molecule); and TLR signaling occurs through MyD88-dependent and TRIF-dependent pathways (Akira et al., 2006; Beutler, 2009 ). The MyD88-dependent pathway is utilized by all TLRs except TLR3 (Miggin and O'Neill, 2006) .
To evaluate specific components of the MyD88 pathway on EtOH consumption, we examined different tests of EtOH consumption that model chronic, intermittent, and binge-like drinking in male and female control mice versus mice lacking CD14, TLR2, TLR4, or MyD88. We chose 2 tests of longterm access to EtOH (2-bottle choice [2BC] continuous and intermittent models) and 2 tests of limited access (drinkingin-the-dark [DID] with and without free choice). Compared to 2BC continuous drinking, 2BC intermittent (everyother-day) access can promote higher alcohol intake. DID was chosen as a binge-like model of consumption that produces acutely elevated blood alcohol levels. Different EtOH exposure paradigms can produce distinct changes in patterns of gene expression in mouse brain despite producing similar amounts of EtOH intake (Osterndorff-Kahanek et al., 2013) . Also, drinking effects in a particular null mutant can depend on sex and the drinking protocol . These findings highlight the importance of examining genotype effects in male and female animal models using multiple tests of EtOH consumption. Based on our previous studies of mice lacking different immune-related genes (Blednov et al., 2012b) , we predicted that EtOH consumption and preference would decrease in mice lacking components of the MyD88-dependent pathway.
MATERIALS AND METHODS

Mice
Generation of Cd14 (B6.129S4-Cd14 /J, stock #009088) knockout (KO) mice were described previously (Hou et al., 2008; Moore et al., 2000; Wooten et al., 2002) . The C57BL/10ScN mouse was used as a TLR4-deficient model (B6.B10ScN-Tlr4 lps-del /JthJ, stock #007227). This strain is homozygous for a deletion allele Tlr4 lps-del that causes spontaneous deletion of TLR4, resulting in the absence of TLR4 mRNA and protein. All mutant strains were purchased from The Jackson Laboratory (Bar Harbor, ME) and were backcrossed on a C57BL/ 6J genetic background more than 6 generations, and thus, the C57BL/6J inbred strain is an appropriate control for these studies (https://www.jax.org/jax-mice-and-services/customer-support/technical-support/breeding-and-husbandry-support/considerations-forchoosing-controls). C57BL/6J mice were taken from a colony maintained at The University of Texas (UT) at Austin (original breeders were purchased from The Jackson Laboratory). Mice were grouphoused 4 to 5 per cage based on genotype and sex. The humidity and temperature of the rooms were kept constant, and they were maintained a 12/12 hour light/dark cycle with lights on at 7 AM.
Food and water were available ad libitum. Behavioral testing began when the mice were at least 2 months old, and mice were weighed every 4 to 6 days. All experiments were conducted in isolated behavioral testing rooms in the Animal Resource Center at UT Austin with a reversed light/dark cycle to avoid external distractions. Before beginning experiments, mice were moved to their experimental room and remained there for 1 to 2 weeks to adapt to the new light/dark cycle. All experiments were approved by the University's Institutional Animal Care and Use Committee.
Two-Bottle Choice
The 24-hour continuous 2BC protocol was carried out as previously described (Blednov et al., 2001) , where mice had access to 1 bottle of EtOH and 1 bottle of water at all times. For this and other drinking tests described below, EtOH (Aaper Alcohol and Chemical, Shelbyville, KY) solutions were prepared fresh daily in tap water, and bottles were weighed before placement and after removal from the experimental cages. The location of the EtOH bottle was alternated daily to control for potential side preferences. EtOH consumption (g/kg body weight/24 h) was calculated for each mouse, and values were averaged for each concentration of EtOH. EtOH concentrations were increased from 3 to 21%, with each concentration being presented for 4 days.
Preference for Non-Ethanol Tastants
EtOH-na€ ıve control and mutant mice were tested for saccharin, quinine, and NaCl consumption using a 24-hour 2BC protocol in which 1 bottle contained water and the other contained the tastant solution. Mice were offered a series of increasing concentrations of saccharin (0.00165, 0.0033, 0.0099, 0.0165, and 0.033%) and quinine hemisulfate (0.003, 0.009, 0.0165, 0.03, and 0.06 mM). Sodium chloride was presented in concentrations 75, 150, and 300 mM. For each tastant, the low concentration was always presented first. Each concentration was offered for 4 days, and bottle positions were changed daily.
Two-Bottle Choice-Every-Other-Day
Intermittent (every-other-day [EOD]) access to EtOH increases voluntary drinking in rats (Simms et al., 2008; Wise, 1973) and mice (Melendez, 2011; Rosenwasser et al., 2013) . Mice were given EOD access to EtOH (15 or 20%) and water for 24-hour sessions, and water only was offered on off days (Osterndorff-Kahanek et al., 2013) . The side placement of the EtOH bottles was alternated with each drinking session. The quantity of EtOH consumed was calculated as g/kg body weight/24 h.
One-Bottle Drinking-in-the-Dark
Consumption of EtOH (20%) under binge-like drinking conditions achieves pharmacologically significant blood EtOH levels (Rhodes et al., 2005) . Beginning 3 hours after lights off, the water bottle in each cage was replaced with a bottle containing 20% EtOH. The EtOH bottle remained in place for either 2 hours (days 1 to 3) or 4 hours (day 4) and was then replaced with a water bottle. Bottle positions were changed daily. Except for this short period of EtOH exposure, mice had unlimited access to water. The quantity of EtOH consumed was calculated as g/kg body weight every 2 or 4 hours.
Two-Bottle Choice Drinking-in-the-Dark
This was similar to the 1-bottle DID (1B-DID) test described above by Rhodes and colleagues (2005) except that 2 bottles containing either 20% EtOH or water were used beginning 3 hours after lights off (Blednov and Harris, 2008) . The EtOH and water bottles remained in place for 3 hours. After their removal, mice had unlimited access to 1 bottle of water. Bottle positions were changed daily. The quantity of EtOH consumed was calculated as g/kg body weight/3 h.
Statistical Analysis
Data are reported as the mean AE SEM. The statistics software program GraphPad Prism (GraphPad Software, Inc., La Jolla, CA) was used to perform 1-or 2-way ANOVAs and Bonferroni or Student's t-tests. Data from male and female mice were analyzed separately.
RESULTS
Two-Bottle Choice Drinking
In the 2BC paradigm in which mice could drink either water or increasing concentrations of EtOH solutions (3 to 21%), EtOH intake [effect of genotype: F(1, 36) = 9.7; p < 0.01], and preference [effect of genotype: F(1, 36) = 11.3; p < 0.01], decreased, while total fluid intake increased [effect of genotype: F(1, 36) = 14.2; p < 0.001], in TLR2 KO male mice compared with C57BL/6J control mice ( Fig. 1A-C) . Lack of TLR4 or MyD88 did not alter EtOH consumption or preference in male mice (Table S1 ), but there was a significant genotype 9 concentration interaction effect on EtOH intake [F(6, 240) = 4.1; p < 0.001] and preference [F(6, 240) = 5.5; p < 0.001] in TLR4-deficient male mice (Fig. 1A , B). TLR4 male and female mutant mice had slightly reduced total fluid intake compared to controls [effect of genotype: F(1, 40) = 16.6; p < 0.001 for males and F(1, 34) = 7.1; p < 0.05 for females, Fig. 1C ,F]. No significant genotype differences in EtOH intake, preference, or total fluid intake were found in female mutant mice versus control mice ( Fig. 1D-F ; Table S1 ). There was a significant genotype 9 concentration interaction effect for EtOH intake and preference in female mutant mice as well as a Fig. 1 . Two-bottle choice continuous access drinking in mice lacking TLR2, TLR4, or MyD88. Ethanol (EtOH) intake (g/kg/24 h) (A), preference for EtOH (B), and total fluid intake (g/kg/24 h) (C) in male control (C57BL/6J, n = 26) versus mutant mice (n = 7, 12, and 16 for MyD88 KO, TLR2 KO, and TLR4 mutant, respectively). EtOH intake (g/kg/24 h) (D), preference for EtOH (E), and total fluid intake (g/kg/24 h) (F) in female control (n = 26) versus mutant mice (n = 7 for MyD88 KO; n = 10 for TLR2 KO and TLR4 mutant). Data were analyzed by repeated-measures 2-way ANOVA followed by Bonferroni post hoc tests.
genotype 9 concentration interaction for total fluid intake in female TLR2 and TLR4 mutants (Table S1 ).
Two-Bottle Choice Every-Other-Day Drinking
Over 24 total days of intermittent (EOD) consumption of 15% followed by 20% EtOH, intake and preference decreased in CD14 KO male mice, while total fluid intake increased compared to control mice. There was an effect of genotype on 15% [F(1, 40) = 7.7; p < 0.01] but not 20% EtOH intake; a genotype effect on preference for 15 and 20% EtOH, respectively [F(1, 40) = 11.8; p < 0.01 and F (1, 40) = 7.9; p < 0.01] and a genotype effect on total fluid intake in the presence of 15 and 20% EtOH, respectively [F (1, 40) = 17.9; p < 0.001 and F(1, 40) = 22.3; p < 0.001, Fig Table S2 ]. No significant differences in EtOH intake, preference, or total fluid intake were found in male mice lacking TLR2 ( Fig. 2D -F) or TLR4 ( Fig. 2G-I ) compared to control mice (Table S2) . Surprisingly, MyD88 KO male mice showed significantly increased EtOH intake and preference for both 15 and 20% EtOH solutions [genotype effect on intake of 15 and 20% EtOH, respectively: Fig. 2 . Two-bottle choice-every-other-day drinking in male mice lacking CD14, TLR2, TLR4, or MyD88. Ethanol (EtOH) intake (g/kg/24 h) (A, D, G, J), preference for EtOH (B, E, H, K), and total fluid intake (C, F, I, L) in control (C57BL/6J, n = 26) versus mutant male mice (n = 18 for MyD88 KO, TLR2 KO, and CD14 KO; n = 12 for TLR4 mutant). Data were analyzed by repeated-measures 2-way ANOVA followed by Bonferroni post hoc tests (*p < 0.05, **p < 0.01, ***p < 0.001 compared to control).
F(1, 40) = 10.0; p < 0.01 and F(1, 40) = 17.9; p < 0.001 and genotype effect on preference for 15 and 20% EtOH, respectively: F(1, 40) = 12.8; p < 0.001 and F(1, 40) = 12.7; p < 0.001, Fig. 2J ,K; Table S2 ]. Total fluid intake was slightly reduced in the presence of 15% [effect of genotype: F (1, 40) = 7.2; p < 0.05] but not 20% EtOH ( Fig. 2L ; Table S2 ).
Similar to male mice, CD14 KO female mice showed a large reduction in 15 and 20% EtOH intake and preference and an increase in total fluid intake compared to control mice ( Fig. 3A-C ; Table S3 ). There was an effect of genotype on EtOH intake for 15 and 20% EtOH, respectively, F(1, 36) = 10.1; p < 0.01 and F(1, 36) = 12.7; p < 0.01; a genotype effect on preference for both concentrations, F(1, 36) = 20.6; p < 0.001 and F(1, 36) = 23.4; p < 0.001; and a genotype effect on total fluid intake for both concentrations, F(1, 36) = 38.9; p < 0.001 and F(1, 36) = 20.6; p < 0.001. There were no differences between control and TLR2 KO female mice in any of the parameters ( Fig. 3D-F ;  Table S3 ). TLR4 mutant female mice showed no difference in 15% EtOH intake, increased preference for this concentration [effect of genotype: F(1, 35) = 21.1; p < 0.001], but decreased total fluid intake [F(1, 35) = 38.3; p < 0.001, Fig. 3G-I ; Table S3 ]. The consumption of 20% EtOH [genotype effect: F(1, 35) = 11.3; p < 0.01] and total fluid [genotype effect:F(1, 35) = 26.9; p < 0.001] decreased in Fig. 3 . Two-bottle choice-every-other-day drinking in female mice lacking CD14, TLR2, TLR4, or MyD88. Ethanol (EtOH) intake (g/kg/24 h) (A, D, G, J), preference for EtOH (B, E, H, K), and total fluid intake (C, F, I, L) in control (C57BL/6J, n = 22) versus mutant female mice (n = 15 for TLR4 mutant; n = 16 for MyD88 KO, TLR2 KO, and CD14 KO). Data were analyzed by repeated-measures 2-way ANOVA followed by Bonferroni post hoc tests (*p < 0.05, **p < 0.01, ***p < 0.001 compared to control). Data above the horizontal lines indicate that each point was different from its corresponding control measure at the designated p-level.
TLR4 mutant females with no change in the preference for EtOH. No difference in EtOH intake or preference was found between control and MyD88 KO female mice ( Fig. 3J-L ; Table S3 ). In the presence of 15% EtOH only, total fluid intake decreased slightly in MyD88 KO female mice [effect of genotype: F(1, 36) = 7.2; p < 0.05].
Two-Bottle Choice Drinking-in-the-Dark
As shown in Fig. 4A , TLR2 KO male mice drank less EtOH (20%) compared to control mice in the 2BC-DID test [effect of genotype: F(1, 40) = 10.0; p < 0.01]. Although preference for EtOH was not significantly different, there was a significant genotype 9 time interaction effect [F(8, 320) = 2.3; p < 0.05, Fig. 4B ]. Total fluid intake was not different in control and TLR2 KO mice ( Fig. 4C ; Table S4 ). There were no differences in EtOH intake and preference in TLR4 mutant and control male mice (Fig. 4D,  E) , but total fluid consumption decreased in TLR4 mutants [effect of genotype: F(1, 37) = 4.8; p < 0.05, Fig. 4F ]. MyD88 KO male mice consumed slightly more EtOH than control mice in the 2BC-DID test [effect of genotype: F(1, Fig. 4 . Two-bottle choice drinking-in-the-dark in male mice lacking TLR2, TLR4, or MyD88. Ethanol (EtOH) intake (g/kg/24 h) (A, D, G), preference for EtOH (B, E, H), and total fluid intake (C, F, I) in control (C57BL/6J, n = 22) versus mutant male mice (n = 10, 17, and 20 for MyD88 KO, TLR4 mutant, and TLR2 KO, respectively). Data were analyzed by repeated-measures 2-way ANOVA followed by Bonferroni post hoc tests (*p < 0.05, **p < 0.01 compared to control). 30) = 6.0; p < 0.05], but there was no change in EtOH preference or total fluid intake ( Fig. 4G-I ; Table S4 ).
Similar to TLR2 KO male mice, TLR2 KO female mice showed reduced EtOH intake and preference compared to control mice [genotype effect on intake and preference, respectively: F(1, 26) = 8.8; p < 0.01 and F(1, 26) = 5.0; p < 0.05], and no change in total fluid consumption ( Fig. 5A-C ; Table S4 ). No differences between control and TLR4 or MyD88 mutant female mice were found for any drinking parameters ( Fig. 5D-I ; Table S4 ). However, there was a significant genotype 9 time interaction effect, Fig. 5G ; Table S4 ).
One-Bottle Drinking-in-the-Dark
Only TLR2 KO female mice showed reduced EtOH (20%) intake compared to control mice during 2-hour access in the 1B-DID test (Fig. 6A,B ; Table S5 ). EtOH consumption decreased in female TLR2 KO mice over 5 drinking sessions (four 2-hour and one 4-hour sessions, 1-way ANOVA: F(14, 16) = 4.7; p < 0.05, Fig. 6C,D) . EtOH consumption Fig. 5 . Two-bottle choice drinking-in-the-dark in female mice lacking TLR2, TLR4, or MyD88. Ethanol (EtOH) intake (g/kg/24 h) (A, D, G), preference for EtOH (B, E, H), and total fluid intake (C, F, I) in control (C57BL/6J, n = 16) versus mutant female mice (n = 10, 12, and 16 for MyD88 KO, TLR2 KO, and TLR4 mutant, respectively). Data were analyzed by repeated-measures 2-way ANOVA followed by Bonferroni post hoc tests (*p < 0.05 compared to control).
did not differ in TLR4 male or female mutant mice compared to controls (Table S5 ). Because only 1 EtOH bottle is offered, EtOH preference cannot be measured in this test. Due to limited numbers of MyD88 KO mice, we could not perform the 1B-DID test using these mice.
Preference for Non-Ethanol Tastants
Because changes in taste perception can alter EtOH consumption in mice (Belknap et al., 1993; Blednov et al., , 2010 , we also studied consumption of saccharin, quinine, and NaCl using a 24-hour 2BC test to determine whether altered taste could account for changes in EtOH consumption in the mutants.
As shown in Fig. 7A ,B, only MyD88 KO male mice showed a change (reduction) in preference for saccharin compared to control mice [effect of genotype: F(1, 29) = 11.5; p < 0.01, Table S6 ]. Total fluid intake decreased in MyD88 and TLR4 mutant male mice ( Fig. 7C ; Table S6 ). Total fluid intake also decreased in TLR4 mutant female mice, but increased in TLR2 KO female mice ( Fig. 7D ; Table S6 ).
As shown in Fig. 8A ,B, there was a significant effect of concentration on preference for quinine in all groups. Preference for quinine was reduced in TLR2 KO male and female mice compared to control mice [effect of genotype in males and females, respectively: F(1, 26) = 4.4; p < 0.05 and F(1, 28) = 5.6; p < 0.05]. TLR2 and TLR4 mutant Fig. 6 . One-bottle drinking-in-the-dark in male and female mice lacking TLR2 or TLR4. Ethanol (EtOH) intake (g/kg) after 2 and 4 hours in male (A) and female (B) control (C57BL/6J) versus mutant mice. Total EtOH intake (g/kg) over 5 drinking sessions in male (C) and female (D) control (C57BL/6J) versus mutant mice. Data in panels A and B were analyzed by Student's t-test or 2-way ANOVA, and data in panels C and D were analyzed by 1-way ANOVA (*p < 0.05); males: n = 9 for C57BL/6J; n = 10 for TLR2 KO and TLR4 mutant; females: n = 5 for TLR4 mutant, n = 6 for C57BL/6J and TLR2 KO.
female mice demonstrated a significant interaction between genotype and concentration of quinine (Table S7) . Compared to control mice, total fluid intake was significantly reduced in both male and female mice lacking TLR4 ( Fig. 8C,D ; Table S7 ).
As seen in Fig. 9A ,B, there was a significant effect of concentration on preference for NaCl in all groups. Male and female CD14 and TLR2 KO mice had reduced preference for NaCl compared to control mice [genotype effect in CD14 males and females, respectively: F(1, 26) = 25; p < 0.001 and F(1, 27) = 35.6; p < 0.001 and in TLR2 KO males and females, respectively: F(1, 27) = 4.4; p < 0.05 and F(1, 30) = 5.9; p < 0.05]. Male MyD88 KO mice showed a significant genotype 9 concentration interaction effect ( Fig. 9A,B ; Table S8 ). There were significant decreases in total fluid intake in TLR4 and MyD88 mutant male mice and significant increases in CD14 KO female mice (Fig. 9C,D ; Table S8 ). CD14 and TLR2 KO male mice showed a significant genotype 9 concentration interaction effect (Table S8) .
DISCUSSION
Deletion of certain immune-related genes decreases
EtOH consumption in KO mouse models (reviewed in Mayfield et al., 2016) . Some studies have implicated the TLR4 pathway in EtOH drinking or other behavioral effects of EtOH, but a role for the individual components of TLR signaling had not been given due attention thus far. Here we evaluated TLRs implicated in EtOH's neuroinflammatory and/or behavioral effects (TLR2, TLR4) as well as proteins known to signal through multiple Fig. 7 . Saccharin consumption in mice lacking TLR2, TLR4, or MyD88. Preference for saccharin in male (A) and female (B) control (C57BL/6J) versus mutant mice. Total fluid intake (g/kg/24 h) in male (C) and female (D) mice. Data were analyzed by repeated-measures 2-way ANOVA followed by Bonferroni post hoc tests (*p < 0.05, # p < 0.01, † p < 0.001); males: n = 7, 12, 16, and 24 for MyD88 KO, TLR2 KO, TLR4 mutant, and C57BL/6J, respectively; females: n = 7 for MyD88 KO; n = 10 for TLR2 KO and TLR4 mutant; n = 20 for C57BL/6J. TLRs (CD14, MyD88). We tested male and female mutant and control mice using different tests of voluntary EtOH consumption that model drinking patterns found in alcohol-dependent human subjects (Table 1) . Different EtOH exposure paradigms produce distinct changes in gene expression in mouse prefrontal cortex, and the transcriptome profile following chronic intermittent drinking overlaps with changes induced by immune activation (Osterndorff-Kahanek et al., 2013) , highlighting the importance of comparing the mutant mice in different behavioral models.
Based on our previous findings in mice lacking immunerelated genes (Blednov et al., 2012b) , we predicted that EtOH consumption and preference would also decrease in the mutant mice tested here. However, this was only observed in TLR2 KO and CD14 KO mice. In contrast, deletion of MyD88, the key downstream mediator for most TLRs, had no effect in female mice but increased EtOH intake in limited access tests in male mice. Drinking effects in some mutants depended on the sex of the mice or the EtOH exposure protocol (Table 1 ). A review of many different mouse KO models provides evidence that drinking effects in a given genotype may depend on sex, EtOH concentration and time of exposure, as well as the drinking protocol .
We previously showed that injection of LPS produced prolonged increases in EtOH consumption while lack of CD14 reduced consumption in mice (Blednov et al., 2011) , and initially hypothesized that TLR4 inflammatory signaling was responsible for the increased drinking. Treatment with LPS or chronic intermittent EtOH produced similar changes in mouse brain transcriptomes (Osterndorff-Kahanek et al., 2013) , suggesting that chronic EtOH also alters expression of proinflammatory genes. Although TLR4 is a primary Fig. 8 . Quinine consumption in mice lacking TLR2, TLR4, or MyD88. Preference for quinine in male (A) and female (B) control (C57BL/6J) versus mutant mice. Total fluid intake (g/kg/24 h) in male (C) and female (D) mice. Data were analyzed by repeated-measures 2-way ANOVA followed by Bonferroni post hoc tests (*p < 0.05, # p < 0.01, † p < 0.001 compared to control); males: n = 7 for MyD88 KO; n = 12 for TLR2 KO and TLR4 mutant; n = 16 for C57BL/6J; females: n = 7 for MyD88 KO; n = 10 for TLR2 KO and TLR4 mutant; n = 20 for C57BL/6J.
immune target, LPS can activate other immune mediators, such as TLR2, via co-receptors (van Bergenhenegouwen et al., 2013) . LPS-mediated effects via alternate (non-TLR4) or interacting (TLR4/TLR2) immune pathways may thus explain the increased EtOH drinking that we reported previously. Fig. 9 . NaCl consumption in mice lacking CD14, TLR2, TLR4, or MyD88. Preference for sodium chloride in males (A) and females (B). Total fluid intake (g/kg/24 h) in males (C) and females (D). Data were analyzed by repeated-measures 2-way ANOVA followed by Bonferroni post hoc tests (*p < 0.05, # p < 0.01, † p < 0.001 compared to control); males: n = 7, 10, 11, 16, and 18 for MyD88 KO, CD14 KO, TLR2 KO, TLR4 mutant, and C57BL/ 6J; females: n = 11 for TLR2 and TLR4 mutants; n = 12, 13, and 16 for MyD88 KO, CD14 KO, and C57BL/6J. 
Ethanol (EtOH) intake, ethanol preference (pref.), and total fluid intake in male (M) and female (F) mutant versus control C57BL/6J mice. The concentrations of the EtOH solutions used are listed in parentheses. Effects in CD14 KO mice in the 2BC, 2BC-DID, and 1B-DID tests were taken from our previous publication (Blednov et al., 2012b) . 2BC, 24-hour continuous access 2-bottle choice; 2BC-EOD, 24-hour 2-bottle choice with every-other-day access to ethanol; 2BC-DID, drinking-in-the-dark with 2-bottle choice; 1B-DID, drinking-in-the-dark with access to 1 bottle of ethanol. ↓ indicates reduced response compared with corresponding parameter in control mice; ↑ indicates increased response compared with corresponding parameter in control mice; = indicates no significant difference from control mice.
Our findings in C57BL/10ScN mice are consistent with reports in TLR4 KO mice (Alfonso-Loeches et al., 2010; Pascual et al., 2011) , which also did not support a role for TLR4 in EtOH consumption. These studies agree with a comprehensive INIA-Neuroimmune study in TLR4 KO rats, C57BL/6J mice treated with the specific TLR4 inhibitor (+)-naloxone, and TLR4 knockdown in mouse nucleus accumbens, showing that none of these pharmacologic or genetic manipulations consistently reduced EtOH consumption in any drinking model . Although the TLR4 antagonist T5342126 decreased drinking in EtOHdependent and nondependent mice, this was attributed to nonspecific effects . Inconsistent effects of high-dose (+)-naloxone in mice may also have been due to nonspecific effects as reported in Tanda and colleagues (2016) . In contrast to these negative findings, TLR4 knockdown in the central amygdala (CeA) or ventral tegmental area reduced binge-like drinking in alcohol preferring (P) rats (June et al., 2015; Liu et al., 2011) . The decreased drinking was associated with reduced expression of the GABA A a2 subunit in the CeA (Liu et al., 2011) , indicating that TLR4 may interact with neurotransmitter receptors (or other targets) to regulate EtOH consumption in some animal models of alcohol consumption. Although there is ample evidence that TLR4 mediates alcohol-neuroimmune signaling (Alfonso-Loeches et al., 2010; Bajo et al., 2016; Fernandez-Lizarbe et al., 2009; Zou and Crews, 2014) , a direct causal link between TLR4 and alcohol drinking behavior has not been substantiated. The TLR4 pathway is associated with increased anxiety-related behavior during EtOH withdrawal and release of brain inflammatory mediators (Breese et al., 2008; Pascual et al., 2015) that could potentially play a role in relapse drinking. A study of TLR4 KO adolescent mice showed slightly reduced EtOH preference following intermittent intraperitoneal EtOH treatment (Montesinos et al., 2016b) . Despite the limited evidence for its role in voluntary EtOH drinking, there is consistent evidence that TLR4 mediates the sedative effects of EtOH in mice (Corrigan et al., 2015; Wu et al., 2012) (also see our companion study in Blednov et al., 2017) and rats , as well as a role for the Toll innate immune pathway in EtOH-induced resistance to sedation in Drosophila (Troutwine et al., 2016) .
The most surprising finding of the current study was the increased EtOH drinking seen in MyD88 KO male mice in limited access tests (2BC-EOD and 2BC-DID). Inhibition of MyD88 signaling would be expected to block signaling through all TLRs except TLR3 (Miggin and O'Neill, 2006) . The increased EtOH consumption in MyD88 KO male mice suggests that another signaling branch, mediated by the TRIF-dependent pathway, may be important in binge-like drinking. In support of this, we observed increased expression of several components of TRIF-dependent signaling (e.g., TLR3, TRIF, IRF3) in the prefrontal cortex of C57BL/6J mice after chronic 2BC-EOD drinking, and mice treated with poly(I:C), a TLR3 agonist, also showed increased EtOH consumption in the 2BC-EOD test (Y.A. Blednov, unpublished observations). In addition, EtOH potentiated poly(I:C)-induced blood and brain proinflammatory responses, and this was associated with increased TLR3 expression in mouse brain (Qin and Crews, 2012) . MyD88 can function as a negative regulator of TLR3/TRIF signaling (Johnson et al., 2008; Siednienko et al., 2011) , and this inhibitory mechanism may be impaired in MyD88 KO mice. These findings support further study of the TLR3/TRIF pathway as a potential target for regulating EtOH consumption.
CD14 is a co-receptor for TLRs 1 to 4, 6, 7, and 9 (Zanoni and Granucci, 2013) . Deletion of CD14 would thus be expected to interfere with signaling through these TLRs, but not TLRs 5 and 8. The decreased drinking in CD14 KO mice was not likely due to impaired signaling through TLR4 because deletion of TLR4 itself had no overall effect. The role for TLR2 signaling in CD14 KO mice is, however, less clear. Although decreased EtOH drinking was observed in TLR2 KO and CD14 KO mice in the 2BC test, consistent phenotypes for both of these mutants were not found in the other tests. While TLRs 4, 5, or 8 are not likely involved in the decreased drinking in CD14 KO mice, there is some support for TLR2 in these mice. And unlike TLR4, TLR2 was implicated in EtOH-drinking behavior in different models in male and female mice. Total fluid intake
Total fluid intake and preference for saccharin, quinine, and NaCl in 24-hour 2-bottle choice tests in male (M) and female (F) mutant versus control C57BL/6J mice. Effects in CD14 KO mice were taken from our previous publication (Blednov et al., 2012b) . ↓ indicates reduced response compared with corresponding parameter in control mice; ↑ indicates increased response compared with corresponding parameter in control mice; = indicates no significant difference from control mice.
The dependence of voluntary EtOH intake on sensitivity to sweet taste in mice is well documented (Bachmanov et al., 1996; Belknap et al., 1993; Blednov et al., 2012a; Yoneyama et al., 2008) , and deletion of different types of taste receptors reduced EtOH intake and preference in mice . Most of the mammalian TLRs are also expressed in taste bud cells (Wang et al., 2009) . Furthermore, mice lacking MyD88 (which causes impaired TLR signaling) showed significantly reduced preference for saccharin, while lack of the upstream receptors (TLR2, TLR4) did not alter preference (Table 2) . However, decreased preference for saccharin would not account for the increased EtOH consumption in MyD88 KO mice. Preference for EtOH (especially high concentrations) is also positively correlated with preference for NaCl (Blednov et al., 2010) . TLR2 KO and CD14 KO mice showed reduced preference for NaCl, which might suggest that altered taste perception could contribute to the reduced EtOH intake and preference observed in these mutants. However, TLR2 and CD14 KO mice also showed increased total fluid (water) intake in several drinking tests. Changes in NaCl and water intake in these mutants warrant consideration of a potential role for angiotensin in mediating these effects, and there is some evidence for an association between TLR2 and AGTR1 following EtOH exposure (Wang et al., 2014) . With global KO models, we do not know if the resulting phenotypes are due to central or peripheral deletion of immune-related proteins or if any compensatory changes in other molecular targets in the periphery and/or the brain may account for these findings.
Although overall evidence does not support a role for TLR4 in mediating EtOH consumption, we show that other signaling molecules (e.g., TLR2, CD14) may be involved. We previously reported decreased voluntary EtOH drinking in CD14 KO mice (Blednov et al., 2012b ), and our current findings further support the involvement of CD14 (and/or TLRs that are associated with this co-receptor) in other drinking models in both male and female mice. TLR2 has been implicated in EtOH responses in animal models and human alcoholics (reviewed in Robinson et al., 2014) , and we provide initial evidence that it may be important in regulating EtOH consumption in different drinking tests. In addition, the MyD88 KO model implicates TLR3 in EtOH drinking and supports future studies investigating this immune mediator. We show that inhibiting different components of the MyD88 pathway can produce opposite effects on EtOH drinking, and these effects depend on sex and/or the EtOH exposure procedure. Other studies also support the importance of examining different drinking models (Osterndorff-Kahanek et al., 2013) and including both male and female subjects (Pascual et al., 2016) . The review by Mayfield and colleagues (2016) further demonstrates the potential impact of sex and the EtOH exposure conditions on EtOH consumption in different KO mouse models.
In summary, specific MyD88 signaling components differentially regulated EtOH consumption in mice. In general, deletion of CD14 or TLR2 reduced EtOH drinking while deletion of MyD88 surprisingly increased drinking. Deletion of TLR4 did not significantly alter EtOH consumption in any test. The effects in some of the null mutants depended on the EtOH exposure protocol, suggesting that specific patterns of brain gene expression induced by the pattern of drinking may underlie some of the alcohol-related phenotypes.
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